DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Acetamide is an investigational drug.
There have been 14 clinical trials for Acetamide. The most recent clinical trial was a Phase 2 trial, which was initiated on August 15th 2018.
The most common disease conditions in clinical trials are Depressive Disorder, Schizophrenia, and Inflammation. The leading clinical trial sponsors are California Pacific Medical Center Research Institute, St. Michael's Hospital, Toronto, and Weill Medical College of Cornell University.
There is one US patent protecting this investigational drug and twenty-seven international patents.
Recent Clinical Trials for Acetamide
|Senicapoc and Dehydrated Stomatocytosis||Quest Diagnostics||Phase 3|
|Senicapoc and Dehydrated Stomatocytosis||Boston Children’s Hospital||Phase 3|
|Modafinil's Effects on Cognition in Remitted MDD||Ontario Ministry of Health and Long Term Care||Phase 3|
Top disease conditions for Acetamide
Top clinical trial sponsors for Acetamide
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Acetamide||Start Trial||Efficient and scalable synthesis of 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester and its structural analogs||ARIAGEN, INC. (Menlo Park, CA)||Start Trial|
|Acetamide||Start Trial||Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activity||CuRNA, Inc. (Miami, FL)||Start Trial|
|Acetamide||Start Trial||Conductive fibrous materials||Agency for Science, Technology and Research (Singapore, SG)||Start Trial|
|Acetamide||Start Trial||Anti-inflammatory agents||Resverlogix Corp. (Calgary, Alberta, CA)||Start Trial|
|Acetamide||Start Trial||P38 MAP kinase inhibitors||Respivert Ltd. (Buckinghamshire, GB)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Acetamide||European Patent Office||EP2836485||2032-03-17||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|